<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02236</article-id><article-id pub-id-type="doi">10.7554/eLife.02236</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-10609"><name><surname>Xiong</surname><given-names>Xiufang</given-names></name><aff><addr-line><named-content content-type="department">Division of Radiation and Cancer Biology, Department of Radiation Oncology</named-content></addr-line>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10610"><name><surname>Zhao</surname><given-names>Yongchao</given-names></name><aff><addr-line><named-content content-type="department">Division of Radiation and Cancer Biology, Department of Radiation Oncology</named-content></addr-line>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10611"><name><surname>Tang</surname><given-names>Fei</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14472"><name><surname>Wei</surname><given-names>Dongping</given-names></name><aff><addr-line><named-content content-type="department">Division of Radiation and Cancer Biology, Department of Radiation Oncology</named-content></addr-line>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10612"><name><surname>Thomas</surname><given-names>Daffyd</given-names></name><aff><addr-line><named-content content-type="department">Department of Pathology</named-content></addr-line>, <institution>University of Michigan Medical School and Comprehensive Cancer Center</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10613"><name><surname>Wang</surname><given-names>Xiang</given-names></name><aff><addr-line><named-content content-type="department">Division of Radiation and Cancer Biology, Department of Radiation Oncology</named-content></addr-line>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16491"><name><surname>Liu</surname><given-names>Yang</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16785"><name><surname>Zheng</surname><given-names>Pan</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-10252"><name><surname>Sun</surname><given-names>Yi</given-names></name><aff><addr-line><named-content content-type="department">Division of Radiation and Cancer Biology, Department of Radiation Oncology</named-content></addr-line>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country><email>sunyi@umich.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1165"><name><surname>Prives</surname><given-names>Carol</given-names></name><role>Reviewing editor</role><aff><institution>Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>08</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02236</elocation-id><supplementary-material><ext-link xlink:href="elife-02236-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>08</day><month>01</month><year>2014</year></date><date date-type="accepted"><day>20</day><month>08</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, Xiong et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Xiong et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Cell-based studies showed that several Mdm2-binding ribosomal proteins, upon overexpression, stabilize and activate p53.  In contrast, here we show in a mouse knockout study that Mdm2-binding ribosomal protein S27-like (Rps27l), upon disruption, activates p53.  Germline inactivation of <italic>Rps27l</italic> triggers ribosomal stress to stabilize Mdm2, which degrades Mdm4 to reduce Mdm2-Mdm4 E3 ligase towards p53, leading to p53-dependent apoptotic depletion of hematopoietic stem cells and postnatal death, which is rescued by <italic>Trp53</italic> deletion.  Paradoxically, while increased p53 is expected to inhibit tumorigenesis, <italic>Rps27l<sup>-/-</sup>;Trp53<sup>+/-</sup></italic> mice develop lymphomas at higher incidence with p53 loss-of-heterozygosity and severe genome aneuploidy, suggesting that <italic>Rps27l</italic> disruption impose a selection pressure against p53. Thus, Rps27l has dual functions in p53 regulation: under <italic>Trp53<sup>+/+</sup></italic> background, <italic>Rps27l</italic> disruption triggers ribosomal stress to induce p53 and apoptosis, whereas under <italic>Trp53<sup>+/-</sup></italic> background, <italic>Rps27l</italic> disruption triggers genomic instability and <italic>Trp53</italic> deletion to promote tumorigenesis. Our study provides a new paradigm of p53 regulation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All the animal procedures were approved by the University of Michigan Committee on Use and Care of Animals (Protocol # PRO00004764). Animal care was provided in accordance with the principles and procedures outlined in the National Research Council Guide for the Care and Use of Laboratory Animals.</p></fn></fn-group></back></article>